Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease.

MLA

Lehmann, Sylvain, et al. “Clarifying the Association of CSF Aβ, Tau, BACE1, and Neurogranin with AT(N) Stages in Alzheimer Disease.” Molecular Neurodegeneration, vol. 19, no. 1, Oct. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s13024-024-00755-3.

APA

Lehmann, S., Schraen-Maschke, S., Buée, L., Vidal, J.-S., Delaby, C., Hirtz, C., Blanc, F., Paquet, C., Allinquant, B., Bombois, S., Gabelle, A., & Hanon, O. (2024). Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease. Molecular Neurodegeneration, 19(1), 1–14. https://doi.org/10.1186/s13024-024-00755-3

Chicago

Lehmann, Sylvain, Susanna Schraen-Maschke, Luc Buée, Jean-Sébastien Vidal, Constance Delaby, Christophe Hirtz, Frédéric Blanc, et al. 2024. “Clarifying the Association of CSF Aβ, Tau, BACE1, and Neurogranin with AT(N) Stages in Alzheimer Disease.” Molecular Neurodegeneration 19 (1): 1–14. doi:10.1186/s13024-024-00755-3.